-
IMCR Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Immunocore (IMCR)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 537.77 mm | 537.77 mm | 537.77 mm | 537.77 mm | 537.77 mm | |
Cash burn (monthly) | 98.35 mm | (no burn) | 2.83 mm | 5.05 mm | 382.25 k | |
Cash used (since last report) | 274.58 mm | n/a | 7.91 mm | 14.11 mm | 1.07 mm | |
Cash remaining | 263.18 mm | n/a | 529.85 mm | 523.66 mm | 536.70 mm | |
Runway (months of cash) | 2.7 | n/a | 187.0 | 103.6 | 1404.1 |
13F holders | Current |
---|---|
Total holders | 139 |
Opened positions | 138 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 1.24 tn |
Total shares | 45.74 mm |
Total puts | 134.50 k |
Total calls | 152.20 k |
Total put/call ratio | 0.9 |
Largest owners | Shares | Value |
---|---|---|
Wellington Management | 6.38 mm | $216.23 bn |
RTW Investments | 4.87 mm | $165.04 bn |
FMR | 4.81 mm | $163.10 bn |
T. Rowe Price Investment Management | 2.99 mm | $101.41 mm |
T. Rowe Price | 2.83 mm | $96.00 mm |
Malin Life Sciences | 2.11 mm | $111.40 mm |
Primecap Management | 1.95 mm | $66.12 bn |
Baker Bros. Advisors | 1.52 mm | $51.35 bn |
General Atlantic | 1.26 mm | $42.76 bn |
BLVGF Bellevue | 1.15 mm | $39.13 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 May 24 | Baker Bros. Advisors | Non-Qualified Share Option Ordinary Shares | Grant | Acquire A | Yes | No | 46.05 | 12,925 | 595.20 k | 12,925 |
28 May 24 | Baker Bros. Advisors | Non-Qualified Share Option Ordinary Shares | Grant | Acquire A | Yes | No | 46.05 | 12,925 | 595.20 k | 12,925 |
23 May 24 | Kristine Peterson | Share Option Ordinary Shares | Grant | Acquire A | No | No | 50.47 | 14,534 | 733.53 k | 14,534 |
23 May 24 | Roy Steven Herbst | Share Option Ordinary Shares | Grant | Acquire A | No | No | 50.47 | 14,534 | 733.53 k | 14,534 |